Publications

Xu J, Yan Y, Xiang X, Jiang P, Hu X, Yang W. Gastric Perivascular Epithelioid Cell Tumor (PEComa). Am J Clin Pathol. 2019,152(2):221-229.

Pan T, Xu J, Zhu Y. Self-renewal molecular mechanisms of colorectal cancer stem cells. Int J Mol Med. 2017,39(1):9-20.

Yi C, Huang Y, Yu X, Li X, Zheng S, Ding K, Xu J.Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions. Oncotarget. 2016;7(13):17265-74.

Tan Y, Fu J, Li X, Yang J, Jiang M, Ding K, Xu J, Li J, Yuan Y.A minor (<50%) signet-ring cell component associated with poor prognosis in colorectal cancer patients: a 26-year retrospective study in China. PLoS One. 2015;10(3):e0121944. doi: 10.1371/journal.pone.0121944.

Liu Y, Xu J, Jiao Y, Hu Y, Yi C, Li Q, Tong Z, Wang X, Hu L, Xiao Q, Li J, Ding K Neuroendocrine differentiation is a prognostic factor for stage II poorly differentiated colorectal cancer. Biomed Res Int. 2014;2014:789575.

Chen Z, He X, Jia M, Liu Y, Qu D, Wu D, Wu P, Ni C, Zhang Z, Ye J, Xu J, Huang J.β-catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis. PLoS One. 2013;8(5):e63854. doi: 10.1371/journal.pone.0063854.

Ye J, Wu X, Wu D, Wu P, Ni C, Zhang Z, Chen Z, Qiu F, Xu J, Huang J.miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer. PLoS One. 2013 Apr 12;8(4):e60687. doi: 10.1371/journal.pone.0060687. 

Zhou D, Yang L, Zheng L, Ge W, Li D, Zhang Y, Hu X, Gao Z, Xu J Huang Y, Hu H, Zhang H, Zhang H, Liu M, Yang H, Zheng L, Zheng S.Exome capture sequencing of adenoma reveals genetic alterations in multiple cellular pathways at the early stage of colorectal tumorigenesis. PLoS One. 2013;8(1):e53310. doi:10.1371/journal.pone.0053310.